BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 151469)

  • 1. Role of heparin in the interaction of serine proteinases with antithrombin III.
    Stürzebecher J
    Acta Biol Med Ger; 1977; 36(11-12):1893-7. PubMed ID: 151469
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sensitivity of thrombin and plasmin to heparin and antithrombin III.
    Bauer PI; Breuer Z; Machovich R; Büki KG; Horváth I
    Acta Biochim Biophys Acad Sci Hung; 1985; 20(3-4):155-61. PubMed ID: 2944348
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interaction of heparin with lipoproteins - role of the complex in the inactivation of thrombin and plasmin.
    Kecskés E; Büki KG; Bauer PI; Machovich R; Horváth I
    Thromb Haemost; 1983 Apr; 49(2):138-41. PubMed ID: 6223404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Accelerating ability of synthetic oligosaccharides on antithrombin inhibition of proteinases of the clotting and fibrinolytic systems. Comparison with heparin and low-molecular-weight heparin.
    Olson ST; Swanson R; Raub-Segall E; Bedsted T; Sadri M; Petitou M; Hérault JP; Herbert JM; Björk I
    Thromb Haemost; 2004 Nov; 92(5):929-39. PubMed ID: 15543318
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adverse effect of heparin in thrombin-antithrombin III interaction.
    Marciniak E
    Thromb Diath Haemorrh; 1975 Dec; 34(3):748-62. PubMed ID: 1209544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of Arg46 and Arg47 of antithrombin in heparin binding.
    Arocas V; Bock SC; Olson ST; Björk I
    Biochemistry; 1999 Aug; 38(31):10196-204. PubMed ID: 10433728
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tryptophan 60-D in the B-insertion loop of thrombin modulates the thrombin-antithrombin reaction.
    Rezaie AR
    Biochemistry; 1996 Feb; 35(6):1918-24. PubMed ID: 8639675
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The kinetics of hemostatic enzyme-antithrombin interactions in the presence of low molecular weight heparin.
    Jordan RE; Oosta GM; Gardner WT; Rosenberg RD
    J Biol Chem; 1980 Nov; 255(21):10081-90. PubMed ID: 6448846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetic analysis of the heparin-enhanced plasmin--antithrombin III reaction. Apparent catalytic role of heparin.
    Machovich R; Bauer PI; Arányi P; Kecskés E; Büki KG; Horváth I
    Biochem J; 1981 Dec; 199(3):521-6. PubMed ID: 6462134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-catalyzed inhibitor/protease reactions: kinetic evidence for a common mechanism of action of heparin.
    Griffith MJ
    Proc Natl Acad Sci U S A; 1983 Sep; 80(18):5460-4. PubMed ID: 6577437
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a pentosan polysulphate upon thrombin and factor Xa inactivation by antithrombin III.
    Scully MF; Kakkar VV
    Biochem J; 1984 Sep; 222(3):571-8. PubMed ID: 6207810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GAGs-potentiated inhibition of thrombin, factor Xa and plasmin in plasma and in a purified system containing antithrombin III - correlation with total charge density.
    Cofrancesco E; Vigo A; Pogliani EM
    Thromb Haemost; 1981 Dec; 46(4):749-51. PubMed ID: 6460339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitory mechanism of serpins. Identification of steps involving the active-site serine residue of the protease.
    Stone SR; Le Bonniec BF
    J Mol Biol; 1997 Jan; 265(3):344-62. PubMed ID: 9018048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of PGI2 on the inactivation of thrombin, factor Xa, and plasmin by antithrombin-III and heparin.
    Blaskó G
    Prostaglandins; 1979 Jul; 18(1):3-9. PubMed ID: 160589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reactivity of a hereditary abnormal antithrombin III fraction in the inhibition of thrombin and factor Xa.
    Tran TH; Bondeli C; Marbet GA; Duckert F
    Thromb Haemost; 1980 Oct; 44(2):92-5. PubMed ID: 7455997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of prothrombinase by antithrombin-heparin at a macroscopic surface.
    Speijer H; Billy D; Willems G; Hemker HC; Lindhout T
    Thromb Haemost; 1995 Apr; 73(4):648-53. PubMed ID: 7495073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombin generation and inactivation in the presence of antithrombin III and heparin.
    Lindhout T; Baruch D; Schoen P; Franssen J; Hemker HC
    Biochemistry; 1986 Oct; 25(20):5962-9. PubMed ID: 3790498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational conversion of antithrombin to a fully activated substrate of factor Xa without need for heparin.
    Huntington JA; Gettins PG
    Biochemistry; 1998 Mar; 37(10):3272-7. PubMed ID: 9521646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The inhibition of the anticoagulant activity of heparin by platelets, brain phospholipids, and tissue factor.
    Ofosu FA; Cerskus AL; Hirsh J; Smith LM; Modi GJ; Blajchman MA
    Br J Haematol; 1984 Jun; 57(2):229-38. PubMed ID: 6733045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Covalent complexes between low molecular weight heparin fragments and antithrombin III - inhibition kinetics and turnover parameters.
    Hoylaerts M; Holmer E; de Mol M; Collen D
    Thromb Haemost; 1983 Apr; 49(2):109-15. PubMed ID: 6868006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.